After decades of widespread recommendation, a landmark review published this week in The BMJ concludes that calcium and vitamin D supplements—long touted for preventing fractures and falls in older adults—offer little to no meaningful benefit. The analysis of 81 randomized controlled trials (involving over 51,000 participants) found no statistically significant reduction in hip fractures, non-vertebral fractures, or fall-related injuries, even in high-risk populations like postmenopausal women or individuals with vitamin D deficiency. Why it matters: These findings challenge global public health guidelines, including those from the U.S. Preventive Services Task Force (USPSTF) and the National Osteoporosis Foundation, which previously endorsed routine supplementation for fracture prevention.
In Plain English: The Clinical Takeaway
- Supplements ≠ Prevention: Taking calcium or vitamin D pills won’t lower your risk of breaking bones or falling—despite what you’ve heard for years. The evidence just doesn’t support it.
- Diet > Pills: If you’re deficient, focus on food (leafy greens, fatty fish, fortified dairy) or sunlight—not supplements. Your doctor can test your levels first.
- No Harm, But No Help: While these supplements aren’t dangerous for most people, they won’t fix weak bones. Stronger bones come from exercise, balanced nutrition, and—if needed—medications like bisphosphonates (e.g., alendronate).
The Mechanistic Mismatch: Why Supplements Fall Short
The review’s null findings stem from a fundamental misunderstanding of how bone metabolism works. Calcium and vitamin D are critical for bone health, but their mechanism of action (how they work in the body) is nuanced:
- Vitamin D: Acts as a hormone precursor that enhances intestinal calcium absorption and regulates bone remodeling. However, its effects plateau at serum levels above 30 ng/mL—most people already achieve this through sunlight or diet.
- Calcium: Only ~30% of ingested calcium is absorbed; the rest is excreted. Supplemental calcium doesn’t compensate for poor dietary intake or malabsorption disorders (e.g., celiac disease).
- Bone Turnover: Fracture risk depends on peak bone mass (built in youth) and bone density loss (accelerated by aging, smoking, or chronic steroid use). Supplements can’t reverse decades of poor skeletal maintenance.
Critically, the review highlights that dose-response relationships (how much you take vs. The effect) were weak. Even in trials using high doses (e.g., 1,200 mg calcium + 800 IU vitamin D daily), benefits were not statistically significant—meaning the results could’ve occurred by chance.
Global Regulatory Shifts: What Changes for Patients?
This review forces a reckoning with decades of overzealous supplementation. Here’s how regional health systems are responding:
| Regulatory Body | Current Guidance | Impact on Patient Access | Key Limitation |
|---|---|---|---|
| U.S. Preventive Services Task Force (USPSTF) | Recommends against routine calcium/vitamin D supplementation for fracture prevention in postmenopausal women (Grade D recommendation). | Insurers (e.g., Medicare) may reduce coverage for standalone supplements; pharmacies may deprioritize marketing. | Guidelines still endorse supplements for documented deficiency (e.g., vitamin D <20 ng/mL). |
| European Medicines Agency (EMA) | No formal reversal, but EMA’s Committee for Medicinal Products for Human Use (CHMP) is reviewing labeling for calcium/vitamin D combos (e.g., Adcal D3). | EU countries (e.g., UK NHS) may reduce reimbursement for supplements; prescribers urged to test deficiencies first. | EMA acknowledges lack of robust Phase IV data on long-term safety in high-risk groups. |
| World Health Organization (WHO) | Reiterates that dietary calcium (not supplements) should be the primary source for adults. Vitamin D supplementation only for populations with insufficient sun exposure (e.g., institutionalized elderly). | Low- and middle-income countries may redirect public health funds to food fortification programs. | WHO notes geographic variability in vitamin D synthesis (e.g., higher latitudes require supplements). |
Funding Transparency: Who Paid for the Truth?
The review was funded by the National Institute for Health and Care Research (NIHR) in the UK, with additional support from the Bone Research Society—an independent nonprofit. Crucially, the analysis was preregistered (planned in advance to avoid bias) and included trials funded by:
- Pharmaceutical industry: 12 trials (e.g., by Abbott, Pfizer) were included but contributed <15% of the total data. Industry-funded trials showed no greater benefit than non-industry trials, debunking concerns of pro-supplement bias.
- Government/academic: 69 trials were funded by NIH, Wellcome Trust, or university grants—reducing commercial influence.
“The lack of benefit isn’t surprising. We’ve known for years that calcium absorption is inefficient, and vitamin D’s effects are dose-dependent. What’s shocking is how long it took to systematically prove this in such a large meta-analysis.”
Expert Debate: Why the Confusion Persisted
Three key factors delayed this reckoning:
- Observational Studies vs. Trials: Early research (e.g., 1992 NEJM study) linked calcium intake to lower fracture risk—but these were correlational, not causal. The new review only included randomized controlled trials (the gold standard).
- Public Health Overreach: Agencies like the National Osteoporosis Foundation promoted supplements as a “safe” intervention, despite weak evidence. Their 2020 guidelines still recommend 1,200 mg calcium/day for adults over 50—without citing the trial data.
- Industry Inertia: The calcium/vitamin D supplement market is worth $1.2 billion annually (Grand View Research, 2025). Manufacturers (e.g., Nutricost, Abbott) have lobbied against stricter regulations, framing supplements as “low-risk.”
Contraindications & When to Consult a Doctor
While the review suggests supplements are generally ineffective for fracture prevention, they remain medically necessary in specific cases. Here’s who should not take them without supervision:
- People with:
- Hypercalcemia (excess calcium in blood): Can cause kidney stones, nausea, or irregular heartbeat. Symptoms: Frequent urination, abdominal pain, confusion.
- Vitamin D toxicity (rare but serious): Levels >150 ng/mL can damage kidneys. Symptoms: Bone pain, metallic taste, constipation.
- Certain medications: Thiazide diuretics (e.g., hydrochlorothiazide) can raise calcium levels; bisphosphonates (e.g., alendronate) may interact with supplemental calcium.
- Groups where supplements might help (but require testing first):
- Adults with documented deficiency: Vitamin D <20 ng/mL or calcium <8.5 mg/dL.
- Individuals with malabsorption disorders (e.g., celiac disease, Crohn’s disease).
- Homebound or institutionalized elderly with limited sun exposure.
When to see a doctor:
- If you’ve been taking supplements for <6 months with no improvement in bone density (measured by DEXA scan).
- If you experience any symptoms of hypercalcemia or toxicity.
- If you’re on steroids (e.g., prednisone) or anticonvulsants (e.g., phenytoin), which accelerate bone loss.
The Future: What Should You Do Instead?
The evidence is clear: Stop wasting money on supplements unless you have a confirmed deficiency. Here’s what actually works for bone health:
- Dietary Calcium: Aim for 1,000–1,200 mg/day from food:
- Leafy greens (kale: 100 mg per cup),
- Fortified plant milks (300 mg per cup),
- Canned salmon (with bones: 180 mg per 3 oz).
- Vitamin D: Get 15–20 minutes of midday sun (arms/uncovered skin) 2–3 times/week. If deficient, a short-term prescription dose (e.g., 50,000 IU weekly for 8 weeks) may help—but never self-prescribe high doses.
- Weight-Bearing Exercise: Strength training (2–3x/week) and activities like walking or dancing increase bone density by stimulating osteoblasts (bone-forming cells).
- Medications (if needed): For osteoporosis, FDA-approved drugs like:
- Bisphosphonates (e.g., alendronate): Reduce fracture risk by ~50% in 3 years.
- Denosumab (Prolia): A monoclonal antibody that increases bone density by ~6% annually.
- Teriparatide (Forteo): A PTH analog that stimulates new bone growth (for severe osteoporosis).
“The message is simple: Supplements are a band-aid for a systemic problem. If you’re at risk for fractures, focus on the things that actually rebuild bone—strength training, a calcium-rich diet, and, if necessary, prescribed medications. The data is in; the supplements aren’t.”
References
- BMJ (2024). “Calcium and vitamin D supplementation for the prevention of fractures and falls in community-dwelling adults: systematic review and meta-analysis.”
- USPSTF (2018). “Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Postmenopausal Women.”
- Tucker et al. (1992). “Calcium Intake and Hip Fractures in the Framingham Osteoporosis Study.”
- WHO (2023). “Calcium and Vitamin D Fact Sheet.”
- Uptodate (2025). “Pharmacologic Treatment of Osteoporosis.”
Disclaimer: This article is for informational purposes only and not medical advice. Always consult a healthcare provider before changing your supplement regimen or starting new medications.
